Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma

Uika Vaishampayan, Michael Glode, Wei Du, Andrew Kraft, Gary Hudes, Jeremy Wright, Maha Hussain

Research output: Contribution to journalArticlepeer-review

130 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences